The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model

Bibliográfalaš dieđut
Váldodahkkit: Krendyukov, A, Kneisel, N, Zhu, J, Merz, C, Richards, D, Gieffers, C, Van Den Eynde, B
Eará dahkkit: Mitchell, T
Materiálatiipa: Conference item
Giella:English
Almmustuhtton: Elsevier 2020